Biblioteca CRAI Dulce Chacón - Universidad Europea de Madrid

CRAI Library - Madrid
Your cart is empty.
My folder ( items) | My account
Image from Google Jackets

Oncologic imaging : urology / Seung Hyup Kim, Jeong Yeon Cho, editors

Contributor(s): Cho, Jeong Yeon,, editor literario | Kim, Seung Hyup,, editor literario
Material type: materialTypeLabelE-bookPublisher: Berlin, Heidelberg : Springer, [2016]Copyright date: 2017Description: 1 recurso en línea (x, 260 páginas) : ilustraciones (algunas a color).ISBN: 3662452189; 9783662452189.Subject: Aparato urinario -- CáncerOnline resources: Acceso a este recurso digital (usuarios Universidad Europea de Madrid)Digital Resources
Contents:
Preface; Contents; Contributors; 1: Renal Tumors; 1.1 Introduction; 1.2 Detection; 1.3 Characterization; 1.3.1 US; 1.3.1.1 Solid Renal Mass; 1.3.1.2 Cystic Renal Mass; 1.3.1.3 Doppler US and€Contrast-ƯEnhanced US; 1.3.2 CT; 1.3.2.1 Unenhanced CT; 1.3.2.2 Contrast Enhancement; 1.3.3 MRI; 1.3.3.1 Signal Intensity; 1.3.3.2 Contrast Enhancement; 1.3.3.3 Diffusion-Weighted Imaging (DWI); 1.3.4 Positron Emission Tomography; 1.3.5 Biopsy; 1.4 Malignant Renal Cell Tumors: Renal Cell Carcinoma; 1.4.1 Pathologic Consideration; 1.4.1.1 Clear Cell Renal Cell Carcinoma.
1.4.1.10 Nuclear Grading of RCC1.4.2 Imaging; 1.4.2.1 Staging; 1.4.2.2 Subtypes of RCC; Clear Cell RCC; Papillary RCC; Chromophobe RCC; Multilocular Cystic RCC; Collecting Duct Carcinoma; Renal Medullary Carcinoma; Mucinous Tubular and Spindle Cell Carcinoma; Xp11.2 Translocation-TFE3 Gene Fusion Carcinoma; Hereditary RCC Syndromes; 1.5 Benign Renal Cell Tumors; 1.5.1 Oncocytoma; 1.5.1.1 Pathologic Consideration; 1.5.1.2 Imaging; 1.5.2 Papillary Adenoma; 1.6 Metanephric Tumors; 1.6.1 Metanephric Adenoma; 1.6.1.1 Pathologic Consideration; 1.6.1.2 Imaging; 1.7 Mesenchymal Tumors.
1.4.1.2 Multilocular Cystic Renal Cell Carcinoma (Multilocular Cystic Neoplasm of Low Malignant Potential)1.4.1.3 Papillary RCC; 1.4.1.4 Chromophobe RCC; 1.4.1.5 Carcinoma of Collecting Duct of Bellini (Collecting Duct Carcinoma); 1.4.1.6 MiTF/TFE Family Translocation- Associated Carcinoma; 1.4.1.7 Mucinous Tubular and Spindle Cell Carcinoma; 1.4.1.8 Renal Cell Carcinoma Associated with End-Stage Renal Disease (ESRD); Acquired Cystic Disease-Associated Renal Cell Carcinoma; Clear Cell Papillary Renal Cell Carcinoma; 1.4.1.9 Unclassified Renal Cell Carcinoma.
1.7.1 Sarcoma1.7.1.1 Pathologic Consideration; Clear Cell Sarcoma of€Kidney; Malignant Rhabdoid Tumor; Other Malignant Mesenchymal Tumors; 1.7.1.2 Imaging; 1.7.2 Angiomyolipoma; 1.7.2.1 Pathologic Consideration; 1.7.2.2 Imaging; US; CT; MRI; 1.7.3 Epithelioid Angiomyolipoma; 1.7.3.1 Pathologic Consideration; 1.7.3.2 Imaging; 1.7.4 Rare Benign Renal Mesenchymal Tumors; 1.7.4.1 Pathologic Consideration; 1.7.4.2 Imaging; 1.8 Cystic Nephroma and€Mixed Mesenchymal and€Epithelial Tumors; 1.8.1 Pathologic Consideration; 1.8.2 Imaging; 1.9 Nephroblastoma.
1.9.1 Pathologic Consideration1.9.2 Imaging; 1.10 Neuroendocrine Tumors; 1.10.1 Pathologic Consideration; 1.10.2 Imaging; 1.11 Lymphoma; 1.11.1 Pathologic Consideration; 1.11.2 Imaging; 1.12 Metastatic Tumors; 1.12.1 Pathologic Consideration; 1.12.2 Imaging; 1.13 Therapeutic Considerations; 1.13.1 Active Surveillance of€Renal Tumor; 1.13.2 Ablation of€Renal Tumor; 1.13.2.1 Introduction; 1.13.2.2 Patient Selection and€Preparation; 1.13.2.3 Procedures; 1.13.2.4 Complications; 1.13.2.5 Follow-Up; 1.13.2.6 Outcomes; 1.13.3 Surgery; 1.13.3.1 Radical Nephrectomy.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Collection Call number Status Date due Barcode Item holds
LIBRO-E NO PRÉSTAMO LIBRO-E NO PRÉSTAMO Madrid Digital Acceso Electrónico (UEM) Ciencias de la Salud RC280 .U74 O536 2016 EB (Browse shelf(Opens below)) Acceso electrónico eBook.20022279
Total holds: 0
Browsing Madrid Digital shelves, Shelving location: Acceso Electrónico (UEM) Close shelf browser (Hides shelf browser)
RC280 .U74 2019 EB Urologic Oncology RC280 .U74 2019 EB Urologic Oncology RC280 .U74 2021 EB Chemotherapy and Immunotherapy in Urologic Oncology : A Guide for the Advanced Practice Provider RC280 .U74 O536 2016 EB Oncologic imaging : urology RC280 .U74 R37 2016 EB Rare Genitourinary Tumors RC280.U74 U674 2015 EB Upper Urinary Tract Urothelial Carcinoma RC280.U74 U765 2015 EB Urological Oncology

SpringerLink

Preface; Contents; Contributors; 1: Renal Tumors; 1.1 Introduction; 1.2 Detection; 1.3 Characterization; 1.3.1 US; 1.3.1.1 Solid Renal Mass; 1.3.1.2 Cystic Renal Mass; 1.3.1.3 Doppler US and€Contrast-ƯEnhanced US; 1.3.2 CT; 1.3.2.1 Unenhanced CT; 1.3.2.2 Contrast Enhancement; 1.3.3 MRI; 1.3.3.1 Signal Intensity; 1.3.3.2 Contrast Enhancement; 1.3.3.3 Diffusion-Weighted Imaging (DWI); 1.3.4 Positron Emission Tomography; 1.3.5 Biopsy; 1.4 Malignant Renal Cell Tumors: Renal Cell Carcinoma; 1.4.1 Pathologic Consideration; 1.4.1.1 Clear Cell Renal Cell Carcinoma.

1.4.1.10 Nuclear Grading of RCC1.4.2 Imaging; 1.4.2.1 Staging; 1.4.2.2 Subtypes of RCC; Clear Cell RCC; Papillary RCC; Chromophobe RCC; Multilocular Cystic RCC; Collecting Duct Carcinoma; Renal Medullary Carcinoma; Mucinous Tubular and Spindle Cell Carcinoma; Xp11.2 Translocation-TFE3 Gene Fusion Carcinoma; Hereditary RCC Syndromes; 1.5 Benign Renal Cell Tumors; 1.5.1 Oncocytoma; 1.5.1.1 Pathologic Consideration; 1.5.1.2 Imaging; 1.5.2 Papillary Adenoma; 1.6 Metanephric Tumors; 1.6.1 Metanephric Adenoma; 1.6.1.1 Pathologic Consideration; 1.6.1.2 Imaging; 1.7 Mesenchymal Tumors.

1.4.1.2 Multilocular Cystic Renal Cell Carcinoma (Multilocular Cystic Neoplasm of Low Malignant Potential)1.4.1.3 Papillary RCC; 1.4.1.4 Chromophobe RCC; 1.4.1.5 Carcinoma of Collecting Duct of Bellini (Collecting Duct Carcinoma); 1.4.1.6 MiTF/TFE Family Translocation- Associated Carcinoma; 1.4.1.7 Mucinous Tubular and Spindle Cell Carcinoma; 1.4.1.8 Renal Cell Carcinoma Associated with End-Stage Renal Disease (ESRD); Acquired Cystic Disease-Associated Renal Cell Carcinoma; Clear Cell Papillary Renal Cell Carcinoma; 1.4.1.9 Unclassified Renal Cell Carcinoma.

1.7.1 Sarcoma1.7.1.1 Pathologic Consideration; Clear Cell Sarcoma of€Kidney; Malignant Rhabdoid Tumor; Other Malignant Mesenchymal Tumors; 1.7.1.2 Imaging; 1.7.2 Angiomyolipoma; 1.7.2.1 Pathologic Consideration; 1.7.2.2 Imaging; US; CT; MRI; 1.7.3 Epithelioid Angiomyolipoma; 1.7.3.1 Pathologic Consideration; 1.7.3.2 Imaging; 1.7.4 Rare Benign Renal Mesenchymal Tumors; 1.7.4.1 Pathologic Consideration; 1.7.4.2 Imaging; 1.8 Cystic Nephroma and€Mixed Mesenchymal and€Epithelial Tumors; 1.8.1 Pathologic Consideration; 1.8.2 Imaging; 1.9 Nephroblastoma.

1.9.1 Pathologic Consideration1.9.2 Imaging; 1.10 Neuroendocrine Tumors; 1.10.1 Pathologic Consideration; 1.10.2 Imaging; 1.11 Lymphoma; 1.11.1 Pathologic Consideration; 1.11.2 Imaging; 1.12 Metastatic Tumors; 1.12.1 Pathologic Consideration; 1.12.2 Imaging; 1.13 Therapeutic Considerations; 1.13.1 Active Surveillance of€Renal Tumor; 1.13.2 Ablation of€Renal Tumor; 1.13.2.1 Introduction; 1.13.2.2 Patient Selection and€Preparation; 1.13.2.3 Procedures; 1.13.2.4 Complications; 1.13.2.5 Follow-Up; 1.13.2.6 Outcomes; 1.13.3 Surgery; 1.13.3.1 Radical Nephrectomy.

Online resource; title from PDF title page (SpringerLink, viewed October 7, 2016).

There are no comments on this title.

to post a comment.
Share